Immutep (IMM) News Today → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free IMM Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineImmutep Shares Rise 12% After Positive Data From Eftilagimod Trialmarketwatch.com - April 24 at 1:58 PMWhy Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?finance.yahoo.com - April 24 at 1:58 PMMarket Highlights: Tesla surges after Q1 update, iron ore slumps, and 5 ASX small caps to watch todaymsn.com - April 24 at 1:19 AMWhy Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing highermsn.com - April 24 at 1:19 AMImmutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancerfinance.yahoo.com - April 17 at 9:19 AMImmutep Ltd (PRRUF) Gets a Buy from Bell Pottermarkets.businessinsider.com - April 4 at 11:39 PMPrincess Banton-Lofters Sobs After Missing Chance to 'Say Goodbye' to Her Dad Before His Death (Exclusive)msn.com - March 28 at 12:01 PMAnalyst Issues Buy Rating on Immutep Stock Amid Promising Efti Drug Trial Resultsmarkets.businessinsider.com - March 7 at 10:35 AMImmutep Announces First Clinical Data from 90mg Dosing of Eftifinance.yahoo.com - March 5 at 8:19 AMIndividual investors account for 60% of Immutep Limited's (ASX:IMM) ownership, while institutions account for 29%finance.yahoo.com - February 29 at 7:29 PMImmutep Stock (NASDAQ:IMMP) Insider Tradesbenzinga.com - February 22 at 1:30 AMImmutep Quarterly Activities Report Q2 FY24finance.yahoo.com - January 30 at 8:23 AMJefferies Keeps Their Buy Rating on Immutep Ltd (PRRUF)markets.businessinsider.com - January 14 at 6:47 PMImmutep Ltd ADR YP1Amorningstar.com - January 9 at 7:17 PMJefferies Reaffirms Their Buy Rating on Immutep Ltd (PRRUF)markets.businessinsider.com - December 30 at 1:34 AMImmutep Receives Regulatory Feedback On TACTI-004 Trial In Metastatic NSC Lung Cancermarkets.businessinsider.com - December 21 at 10:09 AMImmutep Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancerfinance.yahoo.com - December 21 at 10:09 AMImmutep Stock (NASDAQ:IMMP) Dividends: History, Yield and Datesbenzinga.com - December 16 at 12:08 AMImmutep receives A$2.6M R&D tax incentive from French Governmentmsn.com - December 7 at 9:32 AMImmutep Receives A$2.6 million R&D Tax Incentive from French Governmentfinance.yahoo.com - December 7 at 9:32 AMImmutep (ASX:IMM) investors are sitting on a loss of 22% if they invested five years agofinance.yahoo.com - November 27 at 5:51 PMImmutep Limited (IMMP) stock price, news, quote & history – Yahoo Financeuk.finance.yahoo.com - November 23 at 8:23 PMImmutep expands sites for INSIGHT-003 NSCLC therapy studymsn.com - November 23 at 3:23 PMImmutep Limited: Immutep Announces Site Expansion for INSIGHT-003 Phase I Trialfinanznachrichten.de - November 22 at 10:38 PMImmutep Ltd ADR IMMPmorningstar.com - November 21 at 3:09 PMImmutep Completes Enrollment in TACTI-003 Phase IIb Trial of Efti and KEYTRUDA® in First Line Metastatic or Recurrent Head and Neck Squamous Cell Carcinomafinance.yahoo.com - November 9 at 8:24 AMImmutep Quarterly Activities Report Q1 FY24finance.yahoo.com - October 31 at 9:41 AMAnalysts Conflicted on These Healthcare Names: Amgen (AMGN), Immutep (IMMP) and Bristol-Myers Squibb (BMY)markets.businessinsider.com - October 27 at 5:44 PMImmutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023finance.yahoo.com - October 24 at 9:46 AMASX drops to one-year low as South32 disappointsafr.com - October 23 at 8:22 AMImmutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancerfinance.yahoo.com - October 23 at 8:22 AMASX Health Stocks: Chimeric leaps 65pc on Phase1A results, Immutep over 12pc on Phase 2msn.com - October 23 at 12:06 AMImmutep Shares Jump 13% on Lung-Cancer Combination Trial Datamarketwatch.com - October 23 at 12:06 AMIt May Be Possible That Immutep Limited's (ASX:IMM) CEO Compensation Could Get Bumped Upfinance.yahoo.com - October 18 at 12:12 AMImmutep Announces Publication of Abstracts at ESMO Congress 2023finance.yahoo.com - October 16 at 9:53 AMImmutep Limited (ASX:IMM): Is Breakeven Near?finance.yahoo.com - September 25 at 10:17 PMCommercial Manufacturing of Eftilagimod Alpha at 2000L Scale Granted Authorization for Clinical Trial Usefinance.yahoo.com - September 21 at 9:01 AMImmutep: Nipping At The Heels Of LAG3.Is It Impressive Enough?seekingalpha.com - September 1 at 9:26 PMImmutep price target suggests stock has much further to goau.investing.com - August 7 at 10:24 AMImmutep Quarterly Activities Report Q4 FY23finance.yahoo.com - July 31 at 8:52 AMImmutep to Present Overall Survival Data in 1st Line Non-Small Cell Lung Cancer Accepted for Oral Presentation at ESMO Congress 2023finance.yahoo.com - July 31 at 8:52 AMHere’s why this ASX All Ords share has ‘a number of shots at goal’fool.com.au - July 3 at 12:15 AMRamsay boasts M&A appeal despite failed KKR bidafr.com - June 29 at 9:43 AMImmutep Secured Third United States Patent For Eftilagimod Alpha In Combination With A PD-1 Pathway Inhibitorbenzinga.com - June 27 at 7:28 PMImmutep Secures Third United States Patent for Eftilagimod Alpha in Combination with a PD-1 Pathway Inhibitorfinance.yahoo.com - June 27 at 9:28 AMImmutep Completes A$80 Million Capital Raisefinance.yahoo.com - June 27 at 9:28 AMImmutep Announced Earlier It Was Granted United States Patent for IMP761, a First-in-Class Agonist Antibody Targeting LAG-3benzinga.com - June 20 at 10:22 AMWilsons Sticks to Its Buy Rating for Immutep Ltd (PRRUF)markets.businessinsider.com - June 14 at 1:25 AMThe 12% return this week takes Immutep's (ASX:IMM) shareholders three-year gains to 96%finance.yahoo.com - June 9 at 7:15 PMImmutep to Participate at the Jefferies Healthcare Conferencefinance.yahoo.com - June 7 at 9:36 AM Get Immutep News Delivered to You Automatically Sign up to receive the latest news and ratings for IMM and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report IMM Media Mentions By Week IMM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMM News Sentiment▼0.040.44▲Average Medical News Sentiment IMM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMM Articles This Week▼41▲IMM Articles Average Week Get Immutep News Delivered to You Automatically Sign up to receive the latest news and ratings for IMM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ARTLW News Today ASCLF News Today AWKNF News Today AXIM News Today BRRGF News Today BCTXW News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:IMM) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immutep Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
